Ito K - Search Results

1

Nivolumab Versus Gemcitabine or Pegylated Liposomal Doxorubicin for Patients With Platinum-Resistant Ovarian Cancer: Open-Label, Randomized Trial in Japan (NINJA).

Hamanishi J, Takeshima N, Katsumata N, Ushijima K, Kimura T, Takeuchi S, Matsumoto K, Ito K, Mandai M, Nakai H, Sakuragi N, Watari H, Takahashi N, Kato H, Hasegawa K, Yonemori K, Mizuno M, Takehara K, Niikura H, Sawasaki T, Nakao S, Saito T, Enomoto T, Nagase S, Suzuki N, Matsumoto T, Kondo E, Sonoda K, Aihara S, Aoki Y, Okamoto A, Takano H, Kobayashi H, Kato H, Terai Y, Takazawa A, Takahashi Y, Namba Y, Aoki D, Fujiwara K, Sugiyama T, Konishi I. Hamanishi J, et al. Among authors: ito k. J Clin Oncol. 2021 Nov 20;39(33):3671-3681. doi: 10.1200/JCO.21.00334. Epub 2021 Sep 2. J Clin Oncol. 2021. PMID: 34473544 Free PMC article. Clinical Trial.

2

[Etoposide/cis-platinum (CDDP) combined chemotherapy for ovarian cancer: evaluation of optimum schedule for CDDP administration in chronic continuous exposure of ovarian cancer cells to low-dose etoposide in vitro].

Murakami F, Kiyozuka Y, Nishimura H, Imamura K, Yakushiji M, Noda T, Adachi S, Ito K, Tamori N, Shintani M. Murakami F, et al. Among authors: ito k. Nihon Sanka Fujinka Gakkai Zasshi. 1993 Feb;45(2):125-32. Nihon Sanka Fujinka Gakkai Zasshi. 1993. PMID: 8429246 Japanese.

3

[Preclinical and clinical studies on a tumor marker, galactosyltransferase associated with tumor (GAT), in ovarian cancer (first report)--preclinical study of GAT assay kit and clinical study of normal level].

Nozawa S, Udagawa Y, Ito K, Susumu N, Sasaki H, Aoki D. Nozawa S, et al. Among authors: ito k. Gan To Kagaku Ryoho. 1993 Feb;20(2):271-7. Gan To Kagaku Ryoho. 1993. PMID: 8434966 Japanese.

4

Feasibility study on protracted infusional 5-fluorouracil and consecutive low-dose cisplatin for advanced gastric cancer.

Kondo K, Murase M, Kodera Y, Akiyama S, Ito K, Yokoyama Y, Takagi H, Shirasaka T. Kondo K, et al. Among authors: ito k. Oncology. 1996 Jan-Feb;53(1):64-7. doi: 10.1159/000227537. Oncology. 1996. PMID: 8570135 Clinical Trial.

5

A phase I study of cisplatin i.p. and carboplatin i.v. with G-CSF in patients with ovarian cancer.

Adachi S, Ito K, Itani Y, Noda T, Shintani M, Kawai S, Beppu K, Ito A, Saito K, Hisanaga H, Fukumoto Y, Tomii Y, Masuda M. Adachi S, et al. Among authors: ito k, ito a. Oncol Rep. 1999 Mar-Apr;6(2):311-5. doi: 10.3892/or.6.2.311. Oncol Rep. 1999. PMID: 10022995 Clinical Trial.

6

A dose-finding study of nedaplatin and cyclophosphamide for patients with gynecological malignancies.

Ito K, Adachi S, Itani Y, Koyama M, Hori K, Chin R, Shintani M, Beppu K, Kawai S, Saito K. Ito K, et al. Jpn J Clin Oncol. 1999 Jun;29(6):299-302. doi: 10.1093/jjco/29.6.299. Jpn J Clin Oncol. 1999. PMID: 10418559 Clinical Trial.

7

Prognostic results of cisplatin IP and carboplatin IV with G-CSF in patients with ovarian cancer.

Adachi S, Itani Y, Ito K, Noda T, Shintani M, Saito K, Furukawa N, Tomii Y. Adachi S, et al. Among authors: ito k. Oncol Rep. 2001 Jan-Feb;8(1):27-31. Oncol Rep. 2001. PMID: 11115564 Clinical Trial.

8

A pilot study of paclitaxel and carboplatin for recurrent ovarian cancer.

Adachi S, Ogasawara T, Ito K, Koyama M, Nagano T, Suzuki A, Yamada T, Nakata Y, Ozawa M. Adachi S, et al. Among authors: ito k. Oncol Rep. 2001 Mar-Apr;8(2):285-8. Oncol Rep. 2001. PMID: 11182041 Clinical Trial.

9

[Two cases of complete response to combination chemotherapy of gemcitabine and docetaxel for recurrent ovarian cancer].

Ito K, Adachi S, Iijima T, Nakatsuji Y, Kimura T, Nobunaga T. Ito K, et al. Gan To Kagaku Ryoho. 2003 Jan;30(1):141-4. Gan To Kagaku Ryoho. 2003. PMID: 12557720 Japanese.

10

Prognostic significance of p53 mutation in suboptimally resected advanced ovarian carcinoma treated with the combination chemotherapy of paclitaxel and carboplatin.

Ueno Y, Enomoto T, Otsuki Y, Sugita N, Nakashima R, Yoshino K, Kuragaki C, Ueda Y, Aki T, Ikegami H, Yamazaki M, Ito K, Nagamatsu M, Nishizaki T, Asada M, Kameda T, Wakimoto A, Mizutani T, Yamada T, Murata Y. Ueno Y, et al. Among authors: ito k. Cancer Lett. 2006 Sep 28;241(2):289-300. doi: 10.1016/j.canlet.2005.10.035. Epub 2006 Feb 3. Cancer Lett. 2006. PMID: 16459017

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,177 results

Search Page

Filters